News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Outcomes in patients with oligoprogression following 1st line IO or ChemoIO
Oct 7, 2024, 16:46

Outcomes in patients with oligoprogression following 1st line IO or ChemoIO

Gerry Hanna, Radiation Oncologist at St James’s Hospital, shared a post on X:

“Very intresting paper by Lauren Julia Brown, Harriet Gee, Eric Hau from Australia. They report outcomes in patients with oligoprogression following 1st line IO or ChemoIO.
Patients who receive radiotherapy have better survival.
Paper link on JTO & JTO CRR.”

Radiotherapy Improves Survival in NSCLC After Oligoprogression on Immunotherapy: A Cohort Study

Authors: Lauren Julia Brown, et al.

Outcomes in patients with oligoprogression following 1st line IO or ChemoIO

 

Outcomes in patients with oligoprogression following 1st line IO or ChemoIO

Source: Gerry Hanna/X

cancer cancer awareness cancer care Dublin Eric Hau fight against cancer Gerry Hanna Global fight against cancer Harriet Gee JTO & JTO CRR Lauren Julia Brown NSCLC OncoDaily Oncology radiotherapy St James's Hospital
Special Coverage
Blog
Apr 22, 2025, 13:59
The systemic therapy options available for mCRPC - National Comprehensive Cancer Network
Science
Apr 22, 2025, 13:49
Joshua Brody: How to measure T-cell BYSTANDER tumor killing to prevent antigen escape after cancer immunotherapy
Blog
Apr 22, 2025, 13:34
Sampad Roy: A potential paradigm shift in breast cancer treatment
Blog
Apr 22, 2025, 13:19
IASLC Board of Directors Elections 2025: Spotlight on Undesignated Seat Candidates
Oncolibrary
Apr 22, 2025, 13:02
Trodelvy and Keytruda Achieve Breakthrough Results, Ushering in a New Era for ADCs in Breast Cancer
Radiotherapy
Apr 22, 2025, 12:05
Success Rate and Survival After Stereotactic Radiotherapy
OncoDaily Pulse
Apr 22, 2025, 11:13
New section on OncoDaily - A space that brings all career opportunities into one place
Oncolibrary
Apr 22, 2025, 11:10
DESTINY-Breast09 trial: Enhertu + Pertuzumab Improves PFS in First-Line HER2+ Metastatic Breast Cancer
Blog
Apr 22, 2025, 11:06
How immune cell baselines may predict CD22 therapy outcomes in Pediatric Cancer - NCI Center for Cancer Research
Blog
Apr 22, 2025, 10:57
Register for MASCC25 at the early bird rate - The Multinational Association of Supportive Care in Cancer
Blog
Apr 22, 2025, 10:51
Amol Akhade: Sacituzumab govitecan plus pembrolizumab shows PFS benefit in metastatic TNBC
Blog
Apr 22, 2025, 10:44
Jeff Hunnicutt: Highlands Oncology Group announces a partnership with Agamon Health